ドイツのデジタルPCR (dPCR)・リアルタイムPCR (qPCR) 市場：2019-2025年
Germany Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025
|ドイツのデジタルPCR (dPCR)・リアルタイムPCR (qPCR) 市場：2019-2025年|
発行: Orion Market Research Pvt Ltd
ドイツのデジタルPCR（dPCR）およびリアルタイムPCR（qPCR）の市場は予測期間中、8.0％のCAGRで成長すると予測されています。ドイツは世界の医薬品R&Dにおける主要国の1つであり、欧州製薬団体連合会 (EFPIA) によると、同国は2017年、医薬品R&Dに約83億米ドルの投資を行っています。医薬品R&Dの成長は、創薬・医薬品開発の成長につながり、PCRおよびqPCR技術の需要を推進する要因となっています。また、ドイツでは癌の有病率が大幅に拡大しており、これも市場成長を促進している主要な理由の1つと予想されています。
当レポートでは、ドイツのデジタルPCR (dPCR)・リアルタイムPCR (qPCR) の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、関連法規制、市場規模の推移・予測、技術・製品・用途など各種区分別の内訳、競合環境、企業シェア、主要企業のプロファイルなどをまとめています。
Germany Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Germany digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.0% during the forecast period. Germany is one of the major destinations for pharmaceutical R&D across the globe. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), the country invested nearly $8.3 billion in pharmaceutical R&D in 2017. This growth in pharma R&D results in the growing number of drug discovery and development, which in turn, is leading the demand for dPCR and qPCR technology in the country. The major life sciences firms operating in Germany include Merck KGaA and Eppendorf AG. These companies are developing software and products for the dPCR and qPCR market, to drive the innovation in drug discovery and development process, which in turn, is supporting the growth of the market in Europe. Along with this, the prevalence of cancer has been increasing significantly in Germany, this is expected to be one of the prime reasons which are promoting the growth of the market.
Further, the growth in the country is also attributed to the presence of large players, such as Eppendorf AG, Merck KGaA, Siemens AG, and many others in the country. These are the key companies adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others to thrive in a competitive environment. For instance, in March 2018 Fast Track Diagnostics (FTD), a subsidiary of Siemens Healthineers launched human papillomavirus (HPV) tests and expanded the STD portfolio. Under the test, the company offers a CE-labelled, real-time PCR kit for the detection of 14 HPV High-Risk subtypes.
The market study of the Germany dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include::
The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
The Report covers: